Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey
Yıl: 2020 Cilt: 18 Sayı: 1 Sayfa Aralığı: 40 - 46 Metin Dili: İngilizce DOI: 10.20518/tjph.771720 İndeks Tarihi: 17-11-2021
Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey
Öz: Objective: Since the detection of the first COVID-19 case in Rize on 20th of March 2020, therewere a total of 229 reported cases until 23 May 2020. There is currently no informationavailable about the asymptomatic COVID-19 cases in Turkey. This study aims to detect the pointprevalence of -19 among tea farmers who came to Rize from other provinces during May 2020.Methods: Among the 40 thousand estimated tea workers who came to Rize in May 2020, a totalof 11,180 PCR results were evaluated. The specimens were collected by healthcare workersworking for the Rize Provincial Directorate of Healh and analyzed in the Reference Laboratoryfor Microbiology of the Ministry of Health. The point prevalence of being PCR positive for -19was calculated. Results: The point prevalence of -19 among asymptomatic tea workers wasfound to be 0.197%. Being -19 positive was not statistically significant with age groups andgender (p= 0.183 and p= 0.234, respectively). Conclusions: Sudden demographic changes insociety is a major challenge for establishing a sustainable control policy for COVID-19. Definingthe asymptomatic proportions of the population is crucial for planning effective controlstrategies. Calculating point prevalence among an asymptomatic population with mass screeningis a useful tool for this purpose.
Anahtar Kelime: Geçici çay işçilerinde kitlesel tarama ile COVID-19 nokta prevelansının belirlenmesi: Türkiye’den bir örnek
Öz: Amaç: Rize’de 20 Mart 2020 tarihinde ilk COVID-19 vakasının tanınmasından itibaren 23 Mayıs 2020 tarihine kadar toplam 229 vaka rapor edilmiştir. Günümüzde Türkiye’de assemptomatik COVID-19 vakaları ile ilgili bir bilgi bulunmamaktadır. Bu çalışmanın amacı diğer illerden Rize’ye Mayıs 2020 döneminde çay tarımı amacı ile gelen kişler arasında COVID-19 nokta prevelansının belirlenmesidir. Yöntem: Rize iline Mayıs 2020 döneminde gelen tahminen 40 bin çay üreticisinde yapılan toplam 11180 PCR testi sonucu değerlendirilmiştir. Örnekler Rize İl Sağlık Müdürlüğü bünyesinde çalışan sağlık personeli tarafından alınmış ve Sağlık Bakanlığı’nın Referans Mikrobiyoloji Laboratuvarında değerlendirilmiştir. COVID-19 açısından pozitif sonucu olanlar için nokta prevelansı hesaplanmıştır. Bulgular: Asemptomatik çay üreticileri arasında COVID-19 nokta prevelansı %0.197 oalrak hesaplanmıştır. COVID-19 yönünden pozitif olmak ile yaş grupları ve cinsiyet arasında istatistiksel olarak anlamlı bir ilişki bulunmamıştır (sırasıyla p=0.183 and p=0.234). Sonuç: Toplumdaki ani demografik değişiklikler, COVID-19 ile mücadelede sürdürülebilir kontrol politikaları belirlenmesinde önemli bir zorluktur. Nüfus içindeki asemptomatik kişilerin belirlenmesi, etkili kontrol stratejilerinin planlanabilmesi için bütük önem taşımaktadır. Kitlesel tarama yöntemi ile asemtomatik bir grup içindeki nokta prevelansının belirlenmesi bu amaca ulaşmak için kullanışlı bir yöntemdir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 46 [online]. Available at: https://apps.who.int/iris/handle/10665/3 31443. Accessed June 10, 2020.
- 2. Turkish Institution of Statistics. Demographic and Migration Statistics [online]. Available at: http://tuik.gov.tr/PreTablo.do?alt_id=1067. Accessed June 10, 2020.
- 3. Ministry of Health. COVID-19 Genel Bilgiler, Epidemiyoloji ve Tanı. Ankara: T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü; 2020 [online, updated 01.06.2020]; Available at: https://COVID19bilgi.saglik.gov.tr/tr/COVI D-19-rehberi.html. Accessed June 10, 2020.
- 4. Ministry of Health. Digital Public Health Database Records. [online]. Available at: https://giris.saglik.gov.tr/. Accessed June 10, 2020. Not publicly available, accessed by written permission.
- 5. CDC. COVID-19 Pandemic Planning Scenarios [online, updated May 2020]. Available at: https://www.cdc.gov/coronavirus/2019- ncov/hcp/planning-scenarios.html. Accessed June 10, 2020.
- 6. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control COVID19. New England Journal of Medicine 2020;382(22):2158-60.
- 7. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S-M, Hayashi K, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020;94:154-5. Epub 2020/03/14.
- 8. Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of COVID-19— studies needed. New England journal of medicine 2020;382(13):1194-6.
- 9. Kish L. A Procedure for Objective Respondent Selection within the Household. Journal of the American Statistical Association 1949;44(247):380-7.
- 10. Ye F, Xu S, Rong Z, Xu R, Liu X, Deng P, et al. Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster. International Journal of Infectious Diseases 2020;94:133-8.
- 11. Jing C, Wenjie S, Jianping H, Michelle G, Jing W, Guiqing H. Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020. Emerging Infectious Disease journal 2020;26(6):1343.
- 12. Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, Zambrano-Achig P, del Campo R, Ciapponi A, et al. False-negative results of initial rt-pcr assays for COVID-19: a systematic review. medRxiv 2020:2020.04.16.20066787.
- 13. Nishiura H, Jung S-m, Linton NM, Kinoshita R, Yang Y, Hayashi K, et al. The extent of transmission of novel coronavirus in Wuhan, China, 2020. Multidisciplinary Digital Publishing Institute; 2020.
- 14. Methodology for estimating point prevalence of SARSCoV-2 infection by pooled RT-PCR testing. Stockholm: ECDC: European Centre for Disease Prevention and Control, 2020.
- 15. Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X, et al. Demographic science aids in understanding the spread and fatality rates of COVID-19. Proceedings of the National Academy of Sciences 2020;117(18):9696-8.
- 16. Treibel TA, Manisty C, Burton M, McKnight Á, Lambourne J, Augusto JB, et al. COVID-19: PCR screening of asymptomatic health-care workers at London hospital. The Lancet 2020;395(10237):1608-10.
- 17. Governorship of Rize [online]. Available at: http://www.rize.gov.tr/haberler. Accessed June 10, 2020.
- 18. HASUDER. COVID-19 Weekly News. Ankara: Association of Public Health Specialists [online]. Available at: https://korona.hasuder.org.tr/hasuderyeni-koronavirus-COVID-19-haber-postasi08-06-2020/. Accessed: June 10. 2020.
- 19. Walter LA, McGregor AJ. Sex- and Gender-specific Observations and Implications for COVID-19. West J Emerg Med 2020;21(3):507-9.
- 20. Organization WH. WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals, version 1.1. World Health Organization, 2018 [online]. Available at: https://www.who.int/medicines/access/an timicrobial_resistance/WHO-EMP-IAU2018_01/en/. Accessed: June 10, 2020.
- 21. Tagarro A, Epalza C, Santos M, SanzSantaeufemia FJ, Otheo E, Moraleda C, et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatrics 2020. Epub 2020/04/09.
- 22. Webb K, Peckham H, Nd G, Raine C, Radziszewska A, Ciurtin C, et al. Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity. Research Square 2020(Doi: 10.21203/rs.3.rs-23651/v1).
- 23. Liu N, Zhang F, Wei C, Jia Y, Shang Z, Sun L, et al. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardesthit areas: Gender differences matter. Psychiatry Research 2020;287:112921.
- 24. Gostic K, Gomez AC, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife 2020;9:e55570.
- 25. Shi F, Xia L, Shan F, Wu D, Wei Y, Yuan H, et al. Large-scale screening of COVID-19 from community acquired pneumonia using infection size-aware classification. arXiv preprint arXiv:200309860. 2020.
| APA | Telatar T, baykal m, Aykanat Yurtsever B, UNER S (2020). Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. , 40 - 46. 10.20518/tjph.771720 |
| Chicago | Telatar Tahsin,baykal mehmet halit,Aykanat Yurtsever Burcu,UNER SARP Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. (2020): 40 - 46. 10.20518/tjph.771720 |
| MLA | Telatar Tahsin,baykal mehmet halit,Aykanat Yurtsever Burcu,UNER SARP Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. , 2020, ss.40 - 46. 10.20518/tjph.771720 |
| AMA | Telatar T,baykal m,Aykanat Yurtsever B,UNER S Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. . 2020; 40 - 46. 10.20518/tjph.771720 |
| Vancouver | Telatar T,baykal m,Aykanat Yurtsever B,UNER S Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. . 2020; 40 - 46. 10.20518/tjph.771720 |
| IEEE | Telatar T,baykal m,Aykanat Yurtsever B,UNER S "Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey." , ss.40 - 46, 2020. 10.20518/tjph.771720 |
| ISNAD | Telatar, Tahsin vd. "Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey". (2020), 40-46. https://doi.org/10.20518/tjph.771720 |
| APA | Telatar T, baykal m, Aykanat Yurtsever B, UNER S (2020). Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. Türkiye Halk Sağlığı Dergisi, 18(1), 40 - 46. 10.20518/tjph.771720 |
| Chicago | Telatar Tahsin,baykal mehmet halit,Aykanat Yurtsever Burcu,UNER SARP Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. Türkiye Halk Sağlığı Dergisi 18, no.1 (2020): 40 - 46. 10.20518/tjph.771720 |
| MLA | Telatar Tahsin,baykal mehmet halit,Aykanat Yurtsever Burcu,UNER SARP Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. Türkiye Halk Sağlığı Dergisi, vol.18, no.1, 2020, ss.40 - 46. 10.20518/tjph.771720 |
| AMA | Telatar T,baykal m,Aykanat Yurtsever B,UNER S Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. Türkiye Halk Sağlığı Dergisi. 2020; 18(1): 40 - 46. 10.20518/tjph.771720 |
| Vancouver | Telatar T,baykal m,Aykanat Yurtsever B,UNER S Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey. Türkiye Halk Sağlığı Dergisi. 2020; 18(1): 40 - 46. 10.20518/tjph.771720 |
| IEEE | Telatar T,baykal m,Aykanat Yurtsever B,UNER S "Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey." Türkiye Halk Sağlığı Dergisi, 18, ss.40 - 46, 2020. 10.20518/tjph.771720 |
| ISNAD | Telatar, Tahsin vd. "Point prevalence for COVID-19 among temporary tea farmers with mass screening: An example from Turkey". Türkiye Halk Sağlığı Dergisi 18/1 (2020), 40-46. https://doi.org/10.20518/tjph.771720 |
